Alkem Lab

Market Cap: Mid Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE540L01014
NSEID: ALKEM
BSEID: 539523

INR

5,682.35

70.7 (1.26%)

BSENSE

Dec 05

BSE+NSE Vol: 14.38 k

{
  "main_header": {
    "sid": 1000019,
    "name": "Alkem Lab",
    "stock_name": "Alkem Lab",
    "full_name": "Alkem Laboratories Ltd",
    "name_url": "stocks-analysis/alkem-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "5,682.35",
    "chg": 70.7,
    "chgp": "1.26%",
    "dir": 1,
    "prev_price": "5,611.65",
    "mcapval": "67,763.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 539523,
    "symbol": "ALKEM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE540L01014",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "14.38 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alkem-lab-1000019-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Alkem Laboratories: Analytical Perspective Shifts Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-downgraded-to-hold-amid-mixed-financial-and-technical-signals-3740649",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AlkemLaboratori_mojoScore_3740649.png",
        "date": "2025-12-02 08:43:34",
        "description": "Alkem Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market assessment reflecting nuanced changes across quality, valuation, financial trends, and technical indicators. This article explores the factors influencing the recent shift in analytical perspective, providing investors with a comprehensive understanding of the company’s current standing."
      },
      {
        "title": "Alkem Laboratories Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-technical-momentum-shifts-amid-mixed-market-signals-3740285",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AlkemLaboratori_technicaldot_3740285.png",
        "date": "2025-12-02 08:10:25",
        "description": "Alkem Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent market data reveals a subtle transition in price dynamics, with technical indicators presenting a mixed outlook for investors navigating the stock's near-term trajectory."
      },
      {
        "title": "How has been the historical performance of Alkem Lab?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-alkem-lab-3739307",
        "imagepath": "",
        "date": "2025-12-01 23:22:14",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profit Growth</strong></p>\n<p>Alkem Lab’s net sales have shown a steady upward trend, increasing from ₹7,357 crore in March 2019 to nearly ₹12,965 crore by March 2025. This represents a compound growth trajectory reflecting the company’s expanding market presence and product portfolio. Operating profit before depreciation and interest (PBDIT) excluding other income rose from approximately ₹1,115 crore in 2019 to over ₹2,512 crore in 2025, indicating improved operational efficiency despite rising raw material and employee costs.</p>\n<p>Incorporating other income, operating profit (PBDIT) climbed to ₹3,006 crore in 2025 from ₹1,202 crore in 2019. Profit before tax surged from ₹955 crore to ₹2,527 crore over the same period, while profit after tax nearly tripled from ₹774 crore to ₹..."
      },
      {
        "title": "Alkem Laboratories Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-technical-momentum-shifts-signal-bullish-outlook-amid-mixed-market-returns-3727614",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AlkemLaboratori_technicaldot_3727614.png",
        "date": "2025-11-25 08:12:51",
        "description": "Alkem Laboratories has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and mildly bearish signals across key indicators. This nuanced market assessment highlights evolving price dynamics within the Pharmaceuticals & Biotechnology sector, as the stock navigates recent evaluation adjustments amid broader market trends."
      },
      {
        "title": "Alkem Laboratories Sees Notable Surge in Derivatives Open Interest Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3725809",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AlkemLaboratori_oi_spurts_by_underlying_3725809.png",
        "date": "2025-11-24 15:01:14",
        "description": "Alkem Laboratories has experienced a significant rise in open interest within its derivatives segment, signalling heightened market activity and evolving investor positioning. This development comes as the stock trades near its 52-week high, amid a backdrop of subdued sector and benchmark indices performance."
      },
      {
        "title": "Alkem Laboratories Sees Notable Surge in Derivatives Open Interest Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3725661",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AlkemLaboratori_oi_spurts_by_underlying_3725661.png",
        "date": "2025-11-24 14:00:54",
        "description": "Alkem Laboratories has experienced a significant rise in open interest within its derivatives segment, signalling a shift in market positioning and investor sentiment. This development comes as the stock trades close to its 52-week high, amid fluctuating volume patterns and sector dynamics in the Pharmaceuticals & Biotechnology industry."
      },
      {
        "title": "Alkem Laboratories Sees Notable Surge in Derivatives Open Interest Amid Market Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3721319",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AlkemLaboratori_oi_spurts_by_underlying_3721319.png",
        "date": "2025-11-21 15:01:09",
        "description": "Alkem Laboratories has experienced a significant rise in open interest within its derivatives segment, signalling heightened market engagement and evolving positioning among traders. This development comes alongside a nuanced price movement and shifting volume patterns, offering insights into potential directional bets in the pharmaceutical sector."
      },
      {
        "title": "Alkem Laboratories Sees Notable Surge in Derivatives Open Interest Amid Market Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-price-action-3721180",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AlkemLaboratori_oi_spurts_by_underlying_3721180.png",
        "date": "2025-11-21 14:01:02",
        "description": "Alkem Laboratories has experienced a significant rise in open interest within its derivatives segment, signalling heightened market engagement and evolving positioning among traders. This development comes alongside a nuanced price movement and volume pattern, reflecting a complex interplay of investor sentiment in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Alkem Laboratories Sees Notable Surge in Derivatives Open Interest Amid Mixed Price Movements",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-price-action-3721042",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AlkemLaboratori_oi_spurts_by_underlying_3721042.png",
        "date": "2025-11-21 13:00:41",
        "description": "Alkem Laboratories has experienced a significant rise in open interest within its derivatives segment, signalling heightened market activity and evolving positioning among traders. Despite a slight retreat in the stock price over recent sessions, the surge in open interest and volume patterns suggests a complex interplay of directional bets and investor sentiment in the pharmaceuticals and biotechnology sector."
      }
    ],
    "total": 466,
    "sid": "1000019",
    "stock_news_url": "https://www.marketsmojo.com/news/alkem-laboratories-1000019"
  },
  "announcements": [
    {
      "caption": "Sustainability Report For Financial Year 2024-2025.",
      "datetime": "02-Dec-2025",
      "details": "Please find enclosed herewith Sustainability Report for Financial year 2024-25.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "25-Nov-2025",
      "details": "Schedule of Analyst / Investor Meet - Intimation",
      "source": "BSE"
    },
    {
      "caption": "GMP Inspection By Ministry Of Health Armenia At The Companys Manufacturing Facility Located At Sikkim India",
      "datetime": "22-Nov-2025",
      "details": "Closure of GMP Inspection by Ministry of Health Armenia at the Companys manufacturing facility located at Sikkim India.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alkem Laboratories Ltd has declared <strong>400%</strong> dividend, ex-date: 08 Aug 25",
          "dt": "2025-08-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Alkem Laboratories: Analytical Perspective Shifts Amid Mixed Financial and Technical Signals

2025-12-02 08:43:34

Alkem Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market assessment reflecting nuanced changes across quality, valuation, financial trends, and technical indicators. This article explores the factors influencing the recent shift in analytical perspective, providing investors with a comprehensive understanding of the company’s current standing.

Alkem Laboratories Technical Momentum Shifts Amid Mixed Market Signals

2025-12-02 08:10:25

Alkem Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent market data reveals a subtle transition in price dynamics, with technical indicators presenting a mixed outlook for investors navigating the stock's near-term trajectory.

How has been the historical performance of Alkem Lab?

2025-12-01 23:22:14

Revenue and Profit Growth

Alkem Lab’s net sales have shown a steady upward trend, increasing from ₹7,357 crore in March 2019 to nearly ₹12,965 crore by March 2025. This represents a compound growth trajectory reflecting the company’s expanding market presence and product portfolio. Operating profit before depreciation and interest (PBDIT) excluding other income rose from approximately ₹1,115 crore in 2019 to over ₹2,512 crore in 2025, indicating improved operational efficiency despite rising raw material and employee costs.

Incorporating other income, operating profit (PBDIT) climbed to ₹3,006 crore in 2025 from ₹1,202 crore in 2019. Profit before tax surged from ₹955 crore to ₹2,527 crore over the same period, while profit after tax nearly tripled from ₹774 crore to ₹...

Alkem Laboratories Technical Momentum Shifts Amid Mixed Market Signals

2025-11-25 08:12:51

Alkem Laboratories has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and mildly bearish signals across key indicators. This nuanced market assessment highlights evolving price dynamics within the Pharmaceuticals & Biotechnology sector, as the stock navigates recent evaluation adjustments amid broader market trends.

Alkem Laboratories Sees Notable Surge in Derivatives Open Interest Amid Market Volatility

2025-11-24 15:01:14

Alkem Laboratories has experienced a significant rise in open interest within its derivatives segment, signalling heightened market activity and evolving investor positioning. This development comes as the stock trades near its 52-week high, amid a backdrop of subdued sector and benchmark indices performance.

Alkem Laboratories Sees Notable Surge in Derivatives Open Interest Amid Market Volatility

2025-11-24 14:00:54

Alkem Laboratories has experienced a significant rise in open interest within its derivatives segment, signalling a shift in market positioning and investor sentiment. This development comes as the stock trades close to its 52-week high, amid fluctuating volume patterns and sector dynamics in the Pharmaceuticals & Biotechnology industry.

Alkem Laboratories Sees Notable Surge in Derivatives Open Interest Amid Market Activity

2025-11-21 15:01:09

Alkem Laboratories has experienced a significant rise in open interest within its derivatives segment, signalling heightened market engagement and evolving positioning among traders. This development comes alongside a nuanced price movement and shifting volume patterns, offering insights into potential directional bets in the pharmaceutical sector.

Alkem Laboratories Sees Notable Surge in Derivatives Open Interest Amid Market Activity

2025-11-21 14:01:02

Alkem Laboratories has experienced a significant rise in open interest within its derivatives segment, signalling heightened market engagement and evolving positioning among traders. This development comes alongside a nuanced price movement and volume pattern, reflecting a complex interplay of investor sentiment in the Pharmaceuticals & Biotechnology sector.

Alkem Laboratories Sees Notable Surge in Derivatives Open Interest Amid Mixed Price Movements

2025-11-21 13:00:41

Alkem Laboratories has experienced a significant rise in open interest within its derivatives segment, signalling heightened market activity and evolving positioning among traders. Despite a slight retreat in the stock price over recent sessions, the surge in open interest and volume patterns suggests a complex interplay of directional bets and investor sentiment in the pharmaceuticals and biotechnology sector.